# Study to Assess the Safety, Tolerance and Efficacy of Tezampanel in Patients With Acute Migraine

> **NCT00567086** · PHASE2 · COMPLETED · sponsor: **TorreyPines Therapeutics** · enrollment: 306 (actual)

## Conditions studied

- Migraine

## Interventions

- **DRUG:** TEZAMPANEL

## Key facts

- **NCT ID:** NCT00567086
- **Lead sponsor:** TorreyPines Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** —
- **Final completion:** 2007-08
- **Target enrollment:** 306 (ACTUAL)
- **Last updated:** 2007-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00567086

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00567086, "Study to Assess the Safety, Tolerance and Efficacy of Tezampanel in Patients With Acute Migraine". Retrieved via AI Analytics 2026-09-04 from https://api.ai-analytics.org/clinical/NCT00567086. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*